文献速递心脑血管急症儿科与产科急症

氯胺酮作为院前苯二氮䓬类抵抗性癫痫持续状态抢救药物的有效性

Effectiveness of Ketamine As a Rescue Drug for Patients Experiencing Benzodiazepine-Resistant Status Epilepticus in the Prehospital Setting.
PubMed 文献 · Crit Care Explor · 2024-12-06
一句话结论院前对足够剂量咪达唑仑抵抗的癫痫持续状态,使用氯胺酮抢救在成人中似乎持续有效,儿童/青少年也观察到相似结果。

这项为期7年、基于人群的观察性研究在服务美国一个大县的911急救系统中开展,评估院前使用氯胺酮抢救对足够剂量咪达唑仑抵抗的癫痫持续状态(SE)的效果。成人及青少年给予氯胺酮100 mg静脉/骨内/肌内/鼻内,儿童给予1 mg/kg肌内/鼻内。81例中57例成人按SE-咪达唑仑+氯胺酮方案处理,56例(98.2%)惊厥迅速终止且院前及到院阶段无复发;15例儿童/青少年中11例迅速终止、4例仅减轻。全部81例中未见可归因于氯胺酮的临床显著并发症。作者认为氯胺酮对成人院前咪达唑仑抵抗性SE似乎持续有效,儿童/青少年也观察到相似结果。

要点

  • 成人及青少年抢救剂量为氯胺酮100 mg,途径为静脉/骨内/肌内/鼻内;儿童为1 mg/kg肌内/鼻内。
  • 57例成人按SE-咪达唑仑+氯胺酮方案处理,56例(98.2%)惊厥迅速终止,院前及到院阶段无复发。
  • 15例儿童/青少年按方案处理,11例SE活动迅速终止,4例仅减轻。
  • 全部81例中未见可归因于氯胺酮的临床显著并发症,尤其无需额外主动干预。
  • 作者认为氯胺酮对成人院前咪达唑仑抵抗性SE似乎持续有效,儿童/青少年也观察到相似结果。

适用人群与场景

  • 院前环境(911急救系统)中经急救员处理的持续性癫痫发作患者,在接受足够剂量咪达唑仑后仍持续发作。
  • 研究覆盖美国一个大县,辖区人口961,000,面积1,769平方英里。
  • 成人年龄18–86岁;另有儿童/青少年病例。

诊断标准与关键阈值

  • 咪达唑仑抵抗性癫痫持续状态:在足够剂量咪达唑仑给药后仍持续发作。

处置流程与药物剂量

  • 成人及青少年:氯胺酮100 mg,途径为静脉、骨内、肌内或鼻内。
  • 儿童:氯胺酮1 mg/kg,途径为肌内或鼻内。
  • 对足够剂量咪达唑仑抵抗的SE,按SE-咪达唑仑+氯胺酮方案由急救员给予氯胺酮抢救。

研究设计与关键结果

  • 研究设计:为期7年、基于人群的观察性研究,评估院前对足够剂量咪达唑仑抵抗的SE患者使用氯胺酮(静脉、骨内、肌内或鼻内)的结局。
  • 81例总病例中,57例成人(18–86岁)接受SE-咪达唑仑+氯胺酮方案,氯胺酮迅速终止惊厥56例(98.2%),院前及到院阶段无复发。
  • 因获批原因,急救员直接给予氯胺酮(未用咪达唑仑)8例成人和1例儿童,全部病例惊厥终止。
  • 15例儿童/青少年按方案处理,氯胺酮迅速终止SE活动11例,仅减轻4例,其中2例回顾性判断涉及非癫痫活动、2例涉及鼻内给药。
  • 全部81例氯胺酮治疗病例中,未见可归因于氯胺酮的临床显著并发症,尤其无需任何额外主动干预。

证据类型、等级与局限

  • 证据类型:为期7年、基于人群的观察性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为氯胺酮对成人院前足够剂量咪达唑仑抵抗的持续性癫痫发作似乎持续有效,儿童/青少年观察到相似结果。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Accumulating basic science data, early clinical findings and various feasibility considerations have provided rationales for administering ketamine as a proposed rescue medication for midazolam-resistant status epilepticus (SE) in the logistically challenging prehospital environment. This report details the multiyear experience of paramedics managing midazolam-resistant SE following the introduction of a ketamine-rescue protocol.

DESIGN: A 7-year, population-based, observational study was conducted to evaluate outcomes of patients treated with IV, intraosseous, intramuscular, or intranasal ketamine for SE despite sufficient midazolam dosings. Tracked outcomes included: 1) rapid/sustained termination of clinical seizures in adults while under paramedics' care; 2) corresponding evaluations in children/adolescents; 3) any concerning observations regarding need for assisted ventilation, intubation, or other active interventions post-ketamine; and 4) any identifiable associations between outcomes and circumstances, demographics, or medical history.

SETTING: Emergency response 9-1-1 system serving a large, diverse U.S. county (jurisdictional population, 961,000/1,769 sq miles).

PATIENTS: Those receiving ketamine from paramedics for persistent seizures.

INTERVENTIONS: Adults and adolescents: 100 mg ketamine IV/intraosseous/intramuscular/intranasal; children: 1 mg/kg intramuscular/intranasal.

MEASUREMENTS AND MAIN RESULTS: Among 81 total cases, 57 involved adults (18-86 yr old) receiving the SE-midazolam + ketamine protocol. Ketamine rapidly terminated convulsions in 56 (98.2%) without recurrence during prehospital and hospital arrival phases. For approved reasons, paramedics administered ketamine directly (no midazolam) in eight adults and one child, terminating convulsions in every case. Among 15 childhood/adolescent cases treated per protocol, ketamine rapidly terminated SE activity in 11, but only mitigated it in four, including two retrospectively judged to involve nonseizure activity and two involving intranasal administration. Among all 81 ketamine-treated cases, there were no identifiable clinically significant complications attributable to ketamine, particularly the need for any additional active interventions.

CONCLUSIONS: Ketamine appeared to be consistently effective in treating adults with ongoing out-of-hospital seizures that were resistant to sufficient dosings of midazolam. Similar results were observed in children/adolescents.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Scheppke KA, Pepe PE, Garay SA, et al. Effectiveness of Ketamine As a Rescue Drug for Patients Experiencing Benzodiazepine-Resistant Status Epilepticus in the Prehospital Setting. Crit Care Explor. 2024. PMID: 39642307. doi:10.1097/CCE.0000000000001186

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。